Howie's going to be soooooooooooo distraught.

 

Darn, shux, goodness gracious.....   Oh, well, that's life.  As Pazdur has been known to say, "deal with it."

Provenge received a 17-0 safety vote which in cancer treatments is unheard of.  Based on the safety profile and the findings of Dr Petrylak and the combined OS of the two trials, I 'thought' the FDA would grant an "conditional approval" of sorts based on the terminal condition of AIPC patients.  But they didn't and certainly at the urging of Dr Scher and others.  

 

We did learn one thing..... there are no 'sure things' in either investing or when it comes to the FDA.  A bit more caution would have served us all well financially.  Perhaps we'll be a bit wiser this time around as the interim approaches?